Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Treat

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Hall'S Journal of Health|December 9, 2022
Sacro-PeptonesJoseph A Treat
Clinical Lung Cancer|May 16, 2009
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histologyEverett E Vokes, Suresh Senan, Joseph A Treat, et al.
Clinical Lung Cancer|August 8, 2013
Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancerGeorge R Simon, Christian Manegold, Scott S Barker, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2014
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancerRalph G Zinner, Coleman K Obasaju, David R Spigel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Hall'S Journal of Health|December 9, 2022
Sacro-PeptonesJoseph A Treat
Clinical Lung Cancer|May 16, 2009
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histologyEverett E Vokes, Suresh Senan, Joseph A Treat, et al.
Clinical Lung Cancer|August 8, 2013
Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancerGeorge R Simon, Christian Manegold, Scott S Barker, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2014
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancerRalph G Zinner, Coleman K Obasaju, David R Spigel, et al.
Pageof 1